Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwMyeloma 2015 | Novel immunotherapies for the treatment of multiple myeloma

At the Myeloma 2015 meeting, Prof Paul Richardson (Dana-Farber Cancer Institute, Boston, MA) provides an overview of potential new immune-based approaches for the treatment of multiple myeloma. Studies of antibodies, checkpoint inhibitors and immunomodulatory drugs are currently in evaluation in multiple clinical trials. Combination approaches are receiving interest too.